# NITROFURANTOIN
> **ANDA208909** · Abbreviated New Drug Application (Generic) · Sponsor: SOMERSET THERAPS LLC · Approved 2025-01-14
## Drug
- **FDA Application Number:** ANDA208909
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NITROFURANTOIN
- **Generic name:** NITROFURANTOIN
- **Active ingredients:** NITROFURANTOIN
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SOMERSET THERAPS LLC
- **Manufacturer:** Somerset Therapeutics, LLC
- **First approval:** 2025-01-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208909)
---
*AI Analytics · CC0 1.0*